Search results
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 day agoThe latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $65.26, denoting a +0.66%...
Analysts Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $73.46
ETF DAILY NEWS· 21 hours agoTwo research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating on the company. Several research analysts ...
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Motley Fool via Yahoo Finance· 6 days agoInstead, this represents a buying opportunity for savvy investors who, like Wood, aim to scoop up...
Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
Zacks via Yahoo Finance· 8 hours agoIntellia's (NTLA) lead genome-editing candidate, NTLA-2001 being developed to treat transthyretin...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoSavvy investors are encouraged to take some profits when a stock rises 20% to 25% above its entry....
Zoom's chief accounting officer sells over $188k in company stock By Investing.com
Investing.com· 3 days agoNotably, the filing included footnotes indicating that the June 9 sale was required to cover tax...